Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.
about
Molecular biology of lung cancer: clinical implicationsAppraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-AnalysisMicro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesNon-coding RNAs in lung cancerDetection of miRNAs with a nanopore single-molecule counterSmall RNA Detection by in Situ Hybridization MethodsSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancerTwo panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.Prognostic value of the MicroRNA regulators Dicer and Drosha in non-small-cell lung cancer: co-expression of Drosha and miR-126 predicts poor survival.Stage and tissue-specific prognostic impact of miR-182 in NSCLC.Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?Nanopore-based detection of circulating microRNAs in lung cancer patients.Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis.Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophagesmiRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor statusMiR-106a is an independent prognostic marker in patients with glioblastoma.miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.Epigenetic Therapy in Lung Cancer - Role of microRNAs.MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.Sequence-Specific Recognition of MicroRNAs and Other Short Nucleic Acids with Solid-State Nanopores.miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.MicroRNAs and lung cancers: from pathogenesis to clinical implicationsNew insights into the roles of ncRNA in the STAT3 pathway.The multiple roles of microRNA-155 in oncogenesis.MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.miRNA detection methods and clinical implications in lung cancer.Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.Bone metastases in lung cancer. Potential novel approaches to therapy.MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia.Hypoxia and DNA repair.MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.
P2860
Q24610335-11A529CA-5CD0-4307-B0C5-1E10C1E91B1FQ26772056-485BEFBC-86E9-4626-B250-1F15066C3531Q26823077-F50C746A-04B4-409B-B711-A2C6CC550BBFQ26866521-E6781DA6-856A-42BF-B167-ED350B6BEA80Q27010091-BD357836-2653-4FB2-B5DF-1359C9BA1359Q27011992-8809DA75-31C0-4AEB-A4F8-CB653C40E670Q33862088-F199499B-2290-40D5-8EE9-53F38CD30E4CQ33889404-5325A8AC-F8ED-44C4-9985-43854BE87839Q34147511-AE8A5126-198A-4004-9571-4BAD56AD984EQ34559564-E605F8D2-CE67-4D53-A95F-5C7EA30EBDE5Q34728853-DCE4BA7C-092B-4C2E-AE20-513BA473AA2DQ35103842-F00508DD-1E17-4657-AF84-27647B55F5DDQ35190111-FCFD1FED-7A34-4804-A360-0169CC9447BEQ35291898-3F2D5490-90CC-4D49-B134-7A0670FB2640Q35561695-A6AE1CB7-1C60-4650-8B46-94589E663E1BQ35760211-40938574-1E3B-4E5D-942A-799B43BE9ABCQ35959329-8AAF8DC0-8F0E-418B-AC14-9BB8F87F8391Q36023315-6F91AAB3-810A-4119-8990-E33512E427B8Q36281362-28517A41-0730-44FC-96EF-6F4ED082292EQ36309555-02579D95-BC25-4054-8573-14F15B6D62CFQ36403453-6723EEE8-CF08-45FB-BD2F-DA1B7AC63847Q36865988-D9DEABC7-9D40-4599-9AED-EFC7364C0F34Q36902949-88893B3A-3452-4EA0-8A78-D22A441A32AFQ36938216-62ECA693-0951-4C0B-8828-44F6EA7B6A55Q37645018-1B4FB7D1-E450-4131-81B9-CAEF17CA5403Q37723138-FEEA77F2-4D97-4E42-A97A-70D4589640C1Q37940013-59036361-BC4A-4A5C-BF6C-6FFCF2CF9F5EQ37985756-8A6066ED-8109-4494-A633-CE3D32C37388Q38005062-1E67B59D-0C98-4E33-AD62-B05D5F64D013Q38024125-792A9BC7-9D00-4610-876D-FD32295627A7Q38145349-3E8AF3BC-17E4-4616-8094-3E1863D076C0Q38174308-B8F4025E-1747-4B63-AAC5-C4BEA3BB02B5Q38282466-25871682-8D98-4F01-94F2-02891D2A2806Q38430180-6F060294-9149-4303-9233-CCB90216E5A2Q38541387-3A8A83C3-FE1A-4D4A-A56C-4DF165E489F2Q38766173-BC6A19DC-7069-4BD4-AD1F-6AF9842A4A44Q38961504-95828E2F-AA36-4DFE-BB6F-20A3D9109ADAQ39042366-142F279F-2382-475C-8DAB-9696EC1DD794Q39433270-9719D6E0-3C08-4C00-8E08-0B205629C0FDQ39452819-2CA80646-7121-433D-BBF9-5C9FE73BE55C
P2860
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@ast
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@en
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@nl
type
label
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@ast
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@en
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@nl
prefLabel
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@ast
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@en
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@nl
P2093
P2860
P356
P1476
Prognostic impact of MiR-155 i ...... ated by in situ hybridization.
@en
P2093
Helge Stenvold
Katrine Eklo
Kenneth Lonvik
Khalid Al-Shibli
Lill-Tove Busund
Roy M Bremnes
Samer Al-Saad
Sigve Andersen
Thomas Berg
Tom Donnem
P2860
P2888
P356
10.1186/1479-5876-9-6
P577
2011-01-10T00:00:00Z
P5875
P6179
1047946930